Literature DB >> 6291176

The reversibility of cancer: evidence that malignancy in human hepatoma cells is gamma-linolenic acid deficiency-dependent.

N Dippenaar, J Booyens, D Fabbri, P Engelbrecht, I E Katzeff.   

Abstract

A further critical test of Horrobin's hypothesis that malignancy in cells may be dependent on gamma-linolenic acid (GLA) deficiency, has revealed that GLA supplementation produces a highly significant reduction in the growth rate (up to 87%) of a cultured human hepatoma cell line, compared with the growth rate of untreated hepatoma cells. This supports our previous suggestion that this hypothesis requires urgent further investigation at all levels including trials in human cancer patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6291176

Source DB:  PubMed          Journal:  S Afr Med J


  5 in total

1.  Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells.

Authors:  Lacy Reynolds; Rohit S Mulik; Xiaodong Wen; Archana Dilip; Ian R Corbin
Journal:  Nanomedicine (Lond)       Date:  2014-01-07       Impact factor: 5.307

2.  Controlled trial of gamma linolenic acid in Duke's C colorectal cancer.

Authors:  M B McIllmurray; W Turkie
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-16

3.  Effects of dietary fish oil on human mammary carcinoma and on lipid-metabolizing enzymes.

Authors:  C E Borgeson; L Pardini; R S Pardini; R C Reitz
Journal:  Lipids       Date:  1989-04       Impact factor: 1.880

4.  Effects of dietary primrose oil on mammary tumorigenesis induced by 7,12-dimethylbenz(a)anthracene.

Authors:  S H el-Ela; K W Prasse; R Carroll; O R Bunce
Journal:  Lipids       Date:  1987-12       Impact factor: 1.880

Review 5.  Effects of exogenous lipids on cancer and cancer chemotherapy. Implications for treatment.

Authors:  C P Burns; B A Wagner
Journal:  Drug Saf       Date:  1993-01       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.